CORRESP Filing
AlphaTON Capital Corp
Date: May 12, 2025 · CIK: 0001095435 · Accession: 0001171843-25-003092
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286961
Letter
Portage Biotech Inc.
Clarence Thomas Building, P.O. Box 4649
Road Town, Tortola, British Virgin Islands, VG1110
Tel: (302) 219-5556
May 12, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller, Esq.
Re: Portage Biotech Inc.
Registration Statement on Form F-3, File No. 333-286961
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Requested Date: May 12, 2025
Requested Time: 9:30 am, Eastern Time
Ladies and Gentlemen:
Portage Biotech Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form F-3 (File No. 333-286961) be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it will be declared and become effective at 9:30 a.m. Eastern time on May 14, 2025, or as soon thereafter as possible, or at such later time as the Company may orally request via telephone call to the staff of the Commission (the "Staff"). The Company hereby authorizes Daniel Cohen of Golenbock Eiseman Assor Bell & Peskoe, LLP, counsel to the Company, to make such request on its behalf.
Please contact our counsel, Daniel Cohen of Golenbock Eiseman Assor Bell & Peskoe LLP, at (212) 907-7336, with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Cohen by telephone when this request for acceleration has been granted.
Sincerely yours,
/s/ Alexander Pickett
Show Raw Text
CORRESP 1 filename1.htm Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649 Road Town, Tortola, British Virgin Islands, VG1110 Tel: (302) 219-5556 May 12, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attention: Tim Buchmiller, Esq. Re: Portage Biotech Inc. Registration Statement on Form F-3, File No. 333-286961 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: May 12, 2025 Requested Time: 9:30 am, Eastern Time Ladies and Gentlemen: Portage Biotech Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form F-3 (File No. 333-286961) be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it will be declared and become effective at 9:30 a.m. Eastern time on May 14, 2025, or as soon thereafter as possible, or at such later time as the Company may orally request via telephone call to the staff of the Commission (the "Staff"). The Company hereby authorizes Daniel Cohen of Golenbock Eiseman Assor Bell & Peskoe, LLP, counsel to the Company, to make such request on its behalf. Please contact our counsel, Daniel Cohen of Golenbock Eiseman Assor Bell & Peskoe LLP, at (212) 907-7336, with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Cohen by telephone when this request for acceleration has been granted. Sincerely yours, /s/ Alexander Pickett Alexander Pickett Chief Executive Officer